These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3098684)

  • 21. Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteins.
    Ray TD; Lewis LA; Gulati S; Rice PA; Ram S
    J Immunol; 2011 Apr; 186(8):4881-94. PubMed ID: 21402895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
    Joiner KA; Scales R; Warren KA; Frank MM; Rice PA
    J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.
    Madico G; Welsch JA; Lewis LA; McNaughton A; Perlman DH; Costello CE; Ngampasutadol J; Vogel U; Granoff DM; Ram S
    J Immunol; 2006 Jul; 177(1):501-10. PubMed ID: 16785547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.
    Schlesinger LS; Horwitz MA
    Infect Immun; 1994 Jan; 62(1):280-9. PubMed ID: 8262640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.
    Ram S; Lewis LA; Agarwal S
    J Biol Chem; 2011 Mar; 286(10):8297-8307. PubMed ID: 21245150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides.
    Agarwal S; Vasudhev S; DeOliveira RB; Ram S
    J Immunol; 2014 Aug; 193(4):1855-63. PubMed ID: 25015832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.
    Estabrook MM; Griffiss JM; Jarvis GA
    Infect Immun; 1997 Nov; 65(11):4436-44. PubMed ID: 9353017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
    Zollinger WD; Moran EE; Devi SJ; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.
    Edwards MS; Nicholson-Weller A; Baker CJ; Kasper DL
    J Exp Med; 1980 May; 151(5):1275-87. PubMed ID: 6989947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialic acid-containing lipopolysaccharides of Salmonella O48 strains--potential role in camouflage and susceptibility to the bactericidal effect of normal human serum.
    Bugla-Płoskońska G; Rybka J; Futoma-Kołoch B; Cisowska A; Gamian A; Doroszkiewicz W
    Microb Ecol; 2010 Apr; 59(3):601-13. PubMed ID: 19844648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci.
    Vogel U; Claus H; Heinze G; Frosch M
    Med Microbiol Immunol; 1997 Oct; 186(2-3):159-66. PubMed ID: 9403845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
    Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.
    Ram S; Sharma AK; Simpson SD; Gulati S; McQuillen DP; Pangburn MK; Rice PA
    J Exp Med; 1998 Mar; 187(5):743-52. PubMed ID: 9480984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
    J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
    [No Abstract]   [Full Text] [Related]  

  • 36. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains.
    Ala'Aldeen DA; Borriello SP
    Vaccine; 1996 Jan; 14(1):49-53. PubMed ID: 8821649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance of Neisseria meningitidis to human serum depends on T and B cell stimulating protein B.
    Müller MG; Moe NE; Richards PQ; Moe GR
    Infect Immun; 2015 Apr; 83(4):1257-64. PubMed ID: 25583528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA; Warren KA; Tam M; Frank MM
    J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.